Large Volume Parenteral (LVP) Market by Product Type, Distribution Channel, End User 2024-2032

1
Global Large Volume Parenteral (LVP) Market
Research and Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Large Volume Parenteral (LVP) Market
  Global Industry Trends, Share, Size, Growth,
  Opportunity and Forecast 2024-2032," the global
  large volume parenteral (LVP) market size reached
  US 9.8 Billion in 2023.
• Factors Affecting the Growth of Large Volume
  Parenteral (LVP) Industry
• Increasing Prevalence of Chronic Diseases
• The large volume parenteral (LVP) market is
  witnessing significant growth driven by the
  rising prevalence of chronic diseases worldwide.
  Chronic diseases, such as cancer, diabetes,
  cardiovascular diseases, and autoimmune
  disorders, require long-term treatment often
  involving intravenous administration of
  medications or fluids.
• As the global population ages and lifestyles
  become increasingly sedentary, the incidence of
  chronic diseases is on the rise. This demographic
  shift has fueled the demand for LVP products,
  which are essential for the delivery of large
  volumes of fluids, electrolytes, and medications
  to patients.

4
Report Highlight and Description

• Significant Technological Advancements in Drug
  Delivery Systems
• Technological advancements in drug delivery
  systems are playing a pivotal role in driving the
  growth of the large volume parenteral (LVP)
  market. As pharmaceutical companies invest in
  research and development to enhance the efficacy,
  safety, and convenience of drug administration,
  new and innovative LVP products are being
  introduced to the market. One significant
  technological advancement contributing to market
  growth is the development of advanced infusion
  pumps and infusion sets.
• These devices enable precise control over the
  administration rate and dosage of parenteral
  medications and fluids, enhancing patient safety
  and treatment outcomes. Furthermore, the
  integration of smart technology and connectivity
  features in infusion pumps allows for remote
  monitoring and real-time data transmission,
  facilitating more efficient and personalized
  patient care.
• Rising Demand for Home Healthcare Services
• The rising demand for home healthcare services is
  a significant factor driving the growth of the
  large volume parenteral (LVP) market.

5
Report Highlight and Description

• As healthcare delivery models evolve to meet the
  changing needs and preferences of patients, there
  is increasing emphasis on providing medical care
  in the comfort and convenience of patients'
  homes. This shift toward home-based care is
  driven by various factors, including demographic
  changes, technological advancements, and efforts
  to contain healthcare costs. One key driver of
  the growing demand for home healthcare services
  is the aging population. With a larger proportion
  of the population entering old age, there is a
  greater prevalence of chronic diseases and
  age-related conditions that require ongoing
  medical management.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/large-volume-parenteral
  -market/requestsample

6
Report Description

• Global Large Volume Parenteral (LVP) Market
  Trends
• The rising healthcare expenditure in North
  America, driven by factors such as increasing
  healthcare demand, technological advancements,
  and the prevalence of chronic diseases, is
  fueling the growth of the LVP market.
  Governments, private healthcare providers, and
  insurance companies are allocating substantial
  resources to enhance healthcare infrastructure,
  expand access to medical services, and improve
  patient outcomes.
• As a result, there is growing investment in
  intravenous therapies and parenteral nutrition
  solutions, driving the demand for LVP products
  across various healthcare settings, including
  hospitals, clinics, and ambulatory care centers.
• Looking forward, IMARC Group expects the market
  to reach US 16.2 Billion by 2032, exhibiting a
  growth rate (CAGR) of 5.6 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/large-volume-parenteral
  -market

7
Report Segmentation

• Breakup by Type
• Soft Bag LVP
• Plastic Bottle LVP
• Glass Bottle LVP
• Breakup by Volume
• 100 ML - 250 ML
• 250 ML - 500 ML
• 500 ML - 1000 ML
• 1000 ML - 2000 ML
• 2000 ML and More
• Breakup by Application
• Therapeutic Injections
• Fluid Balance Injections

8
Report Segmentation

• Nutritious Injections
• Breakup by End Users
• Hospitals
• Clinics
• Others
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

9
Competitive Landscape with Key Players

• Albert David Ltd.
• B. Braun Melsungen AG
• Baxter International Inc.
• BML Parenteral Drugs
• Fresenius Kabi AG
• Grifols S.A
• Otsuka Pharmaceutical Co. Ltd
• Pharmaceutical Solutions Industry Ltd.
• Sichuan Kelun Pharmaceutical Co. Ltd.
• Thermo Fisher Scientific Inc.

10
Key Questions Answered in the Report
11
Key Questions Answered in the Report
12
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Large Volume
  Parenteral (LVP) Market    5.1    Market
  Overview    5.2    Market Performance    5.3  
   Impact of COVID-19  5.4    Market Forecast
• 6     Market Breakup by Type    6.1    Soft Bag
  LVP        6.1.1 Market Trends        6.1.2
  Market Forecast    6.2    Plastic Bottle LVP   
      6.2.1 Market Trends        6.2.2 Market
  Forecast    6.3    Glass Bottle LVP       
  6.3.1 Market Trends        6.3.2 Market
  Forecast7   Market Breakup by Volume       

13
Table of Contents

• 7.1 100 ML - 250 ML
• 7.1.1 Market Trends
• 7.1.2 Market Forecast
• 7.2 250 ML - 500 ML
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 7.3 500 ML - 1000 ML
• 7.3.1 Market Trends
• 7.3.2 Market Forecast
• 7.4 1000 ML - 2000 ML
• 7.4.1 Market Trends
• 7.4.2 Market Forecast
• 7.5 2000 ML and More
• 7.5.1 Market Trends
• 7.5.2 Market Forecast
• 8 Market Breakup by Application
• 8.1 Therapeutic Injections
• 8.1.1 Market Trends
• 8.1.2 Market Forecast

14
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

15
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com